ArticleNature communications2018
CEACAM1 promotes CD8
Open access · goldAbstract read
In one paragraph
Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.
0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
36 citing papers in PubMed, 50 citations in OpenAlex.
- Dual-recognizing antibodies targeting CEACAMs in the tumor microenvironment: towards more precise targeting.Cell communication and signaling : CCS · 2026Review
- Exercise and CD8Journal of molecular medicine (Berlin, Germany) · 2026Review
- Berberine suppresses colon inflammation via integrated modulation of host metabolism, microbial ecology, and innate immune signaling.Theranostics · 2026Article
- CEACAM1 as a mediator of B-cell receptor signaling in mantle cell lymphoma.Nature communications · 2025Article
- SLAMF7 defines subsets of human effector CD8 T cells.Scientific reports · 2024Article
- TIM3 in COVID-19; A potential hallmark?Heliyon · 2024Review
- Emerging druggable targets for immune checkpoint modulation in cancer immunotherapy: the iceberg lies beneath the surface.Apoptosis : an international journal on programmed cell death · 2024Review
- CEACAM expression in anFrontiers in immunology · 2023Article
- CEACAMS 1, 5, and 6 in disease and cancer: interactions with pathogens.Genes & cancer · 2023Review
- Krüppel-like factor 4 regulates the cytolytic effector function of exhausted CD8 T cells.Science advances · 2022Article
- Expression changes of Tim-3 as one of supplementary indicators for monitoring prognosis of liver pathological changes in chronic HBV infection.BMC infectious diseases · 2022Article
- CEACAM-1 Induced CSF3-receptor Downregulation in Bone Marrow Associated With Refractory Neutropenia in Advanced Cirrhosis.Journal of clinical and translational hepatology · 2022Article
- Effects of CEACAM1 in oral keratinocytes on HO-1 expression induced by Candida β-glucan particles.Journal of applied oral science : revista FOB · 2022Article
- The Immunological Synapse: An Emerging Target for Immune Evasion by Bacterial Pathogens.Frontiers in immunology · 2022Review
- Transcriptome analysis following neurotropic virus infection reveals faulty innate immunity and delayed antigen presentation in mice susceptible to virus-induced demyelination.Brain pathology (Zurich, Switzerland) · 2021Article
- Roles and mechanisms of circulating CEACAM1 in the cirrhosis-related intestinal hyperpermeability: in vitro approach.Journal of the Chinese Medical Association : JCMA · 2021Article
- The Optimization and Biological Significance of a 29-Host-Immune-mRNA Panel for the Diagnosis of Acute Infections and Sepsis.Journal of personalized medicine · 2021Article
- Bacterial protein domains with a novel Ig-like fold target human CEACAM receptors.The EMBO journal · 2021Article
- Enhanced expression of immune checkpoint receptors during SARS-CoV-2 viral infection.Molecular therapy. Methods & clinical development · 2021Article
- One Stone, Two Birds: The Roles of Tim-3 in Acute Myeloid Leukemia.Frontiers in immunology · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors at 2 institutions in 1 country.
Vishal KhairnarInstitute of Immunology, University Hospital Essen, Hufelandstrasse 55, 45147, Essen, Germany. vishal.khairnar2@uk-essen.de.ORCID http://orcid.org/0000-0002-3584-7530
Vikas DuhanInstitute of Immunology, University Hospital Essen, Hufelandstrasse 55, 45147, Essen, Germany.
Ashwini M PatilDepartment of Hematology, West German Cancer Center (WTZ), University Hospital Essen, Hufelandstrasse 55, 45147, Essen, Germany.
Fan ZhouInstitute of Immunology, University Hospital Essen, Hufelandstrasse 55, 45147, Essen, Germany.
Hilal BhatInstitute of Immunology, University Hospital Essen, Hufelandstrasse 55, 45147, Essen, Germany.
Christine ThoensInstitute of Virology, Medical Faculty, Heinrich-Heine-University, Universitätsstrasse 1, 40225, Düsseldorf, Germany.
Piyush SharmaInstitute of Immunology, University Hospital Essen, Hufelandstrasse 55, 45147, Essen, Germany.ORCID http://orcid.org/0000-0003-1185-9534
Tom AdomatiInstitute of Immunology, University Hospital Essen, Hufelandstrasse 55, 45147, Essen, Germany.
Sarah-Kim FriendrichInstitute of Immunology, University Hospital Essen, Hufelandstrasse 55, 45147, Essen, Germany.
Judith BezgovsekInstitute of Immunology, University Hospital Essen, Hufelandstrasse 55, 45147, Essen, Germany.
Janine D DreesenInstitute of Anatomy, Medical Faculty, University Hospital Essen, Hufelandstrasse 55, 45147, Essen, Germany.
Gunther WennemuthInstitute of Anatomy, Medical Faculty, University Hospital Essen, Hufelandstrasse 55, 45147, Essen, Germany.ORCID http://orcid.org/0000-0003-3313-2475
Astrid M WestendorfInstitute of Medical Microbiology, Faculty of Medicine, University Hospital Essen, Hufelandstrasse 55, 45122, Essen, Germany.
Gennadiy ZelinskyyInstitute for Virology, University Hospital Essen, Hufelandstrasse 55, 45147, Essen, Germany.
Ulf DittmerInstitute for Virology, University Hospital Essen, Hufelandstrasse 55, 45147, Essen, Germany.
Cornelia HardtInstitute of Immunology, University Hospital Essen, Hufelandstrasse 55, 45147, Essen, Germany.
Jörg TimmInstitute of Virology, Medical Faculty, Heinrich-Heine-University, Universitätsstrasse 1, 40225, Düsseldorf, Germany.
Joachim R GöthertDepartment of Hematology, West German Cancer Center (WTZ), University Hospital Essen, Hufelandstrasse 55, 45147, Essen, Germany.
Philipp A LangClinic of Gastroenterology, Hepatology and Infectious Disease, Heinrich-Heine-University, Moorenstrasse 5, 40225, Düsseldorf, Germany.
Bernhard B SingerInstitute of Anatomy, Medical Faculty, University Hospital Essen, Hufelandstrasse 55, 45147, Essen, Germany.
Karl S LangInstitute of Immunology, University Hospital Essen, Hufelandstrasse 55, 45147, Essen, Germany. karlsebastian.lang@uk-essen.de.
Essen University Hospital · DEHeinrich Heine University Düsseldorf · DE
Funding
Alexander von Humboldt-Stiftung (Alexander von Humboldt Foundation) SKP2010Deutsche Forschungsgemeinschaft (German Research Foundation) LA1419/5-1Deutsche Forschungsgemeinschaft (German Research Foundation) SI1558/3-1
Abstract
Dysfunction of CD8
Indexed as
Adoptive TransferAnimalsAntigens, CDBone Marrow TransplantationCarcinoembryonic AntigenCD8-Positive T-LymphocytesCell Adhesion MoleculesChimeraChronic DiseaseFemaleHumansLymphocyte Specific Protein Tyrosine Kinase p56(lck)Lymphocytic ChoriomeningitisLymphocytic choriomeningitis virusMaleMiceAntigens, CDCarcinoembryonic AntigenCD66 antigensCeacam1 protein, mouseCell Adhesion MoleculesLymphocyte Specific Protein Tyrosine Kinase p56(lck)
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.